activistletters
TriMas Corporation (TRS): Barington Capital Urges Strategic Alternatives Over New CEO Hire After Years of Shareholder Underperformance
Summary
Barington Capital urges TriMas to stop the CEO search and instead pursue strategic alternatives, including a sale of the
activistletters
Air Products & Chemicals (APD): Mantle Ridge Urges Shareholders to Back Director Slate, Citing Integrity Crisis, Poor Returns, and Risky Projects
Summary
Mantle Ridge criticized Air Products’ leadership under Seifi Ghasemi, accusing the company of omitting key facts, misleading shareholders about
activistletters
Intrepid Potash (IPI): Gate City Capital Pushes for Capital Returns, Cost Cuts, and Governance Reforms After Leadership Changes
Summary
Gate City Capital (6.37% owner) urged Intrepid Potash to adopt shareholder-friendly policies, including returning 75% of free cash
activistletters
Vera Bradley (VRA): Fund 1 Investments Urges Strategic Alternatives, Citing Value Destruction and Public Market Challenges
Summary
Fund 1 Investments, Vera Bradley’s largest shareholder, urged the company to explore strategic alternatives, including a sale or
activistletters
FIGS Inc. (FIGS): Baron Capital (18% Holder) Opposes Take-Private Proposal, Urges Company to Stay Public
Summary
Baron Capital (18% owner, FIGS’ largest shareholder) opposes the December 2024 take-private proposal, arguing FIGS has a strong balance
activistletters
BML’s Braden Leonard Opposes Aadi Biosciences (AADI) PIPE Financing, Urges Sale or Cash Return to Shareholders
Summary
BML Investment Partners (9.9% owner) strongly opposes Aadi Bioscience’s December 19, 2024 PIPE-financed “AADI 2.0” plan,
activistletters
Fund 1 Investments Proposes Acquisition of Destination XL (DXLG), Citing Retail Strength and Liquidity Challenges
Summary
Fund 1 Investments submitted a non-binding proposal to acquire all outstanding shares of Destination XL Group (DXLG) it does
activistletters
Goodwood Inc. Targets COSCIENS Biopharma (CSCI) Over Cash Burn, Weak Strategy, and Board Accountability
Summary
Goodwood, owning 8.2% of COSCIENS, criticizes the board for burning $11.6M cash in nine months while generating
activistletters
Goodwood Inc. Sent A Letter To Cosciens Biopharma Inc.
Letter Dated December 19, 2024 From Goodwood, Inc. To Cosciens Biopharma Inc.
GOODWOOD INC.
132 Trafalgar Road
Oakville, Ontario
L6J
activistletters
Lamb Weston (LW): JANA Partners Urges Board and Leadership Overhaul, Warns Sale Should Be Considered
Summary
JANA Partners (5%+ holder) demands significant board and leadership change at Lamb Weston, citing years of underperformance, self-inflicted operational
activistletters
Marlton Partners Challenges 180 Degree Capital (TURN) Board, Urges Capital Return Plan to Eliminate NAV Discount
Summary
Marlton, owning a significant stake in TURN, criticizes CEO/Chair Kevin Rendino and the board for destroying value—NAV
activistletters
Marlton Partners Pushes for Board Change at 180 Degree Capital (TURN), Citing -37% NAV Decline and Governance Failures
Summary
Marlton Partners, owning shares in 180 Degree Capital (TURN), criticizes CEO/Chair Kevin Rendino and the Board for seven
activistletters
Atea Pharmaceuticals (AVIR): BML Investment Partners (8.1% Holder) Urges Strategic Partner Before Phase 3 Trial
Summary
BML Investment Partners (8.1% holder of Atea Pharmaceuticals) questions the lack of insider confidence following favorable Phase 2
activistletters
ModivCare (MODV): Q Investments (14% Holder) Pushes for Board Refresh, Leadership Evaluation, and Strategic Review
Summary
Q Investments (14% shareholder and debt holder of ModivCare) welcomes the December 13 resignations of Chairman Shackelton and director
activistletters
Gabelli Urges Myers Industries (MYE) to Pursue Signature Systems Spin/IPO, Highlighting Undervalued Assets and Capital Allocation Potential
Summary
Gabelli Funds’ December 2024 presentation argues that Myers Industries (MYE) is significantly undervalued and could nearly double in enterprise
activistletters
Stadium Capital Urges Board Overhaul at Sleep Number (SNBR), Citing Backing From Holders of 45% of Shares
Summary
Stadium Capital urges long-tenured Sleep Number directors Stephen Gulis, Michael Harrison, Shelly Ibach, Brenda Lauderback, and Barbara Matas to
activistletters
Daktronics (DAKT) Faces Alta Fox Push for CEO/Chair Split, Poison Pill Removal, and Path to $40+ Share Price
Summary
Alta Fox (12% holder) is pushing for major governance and leadership changes at Daktronics, citing severe underperformance under CEO/
activistletters
Matthews International (MATW): Barington Capital Seeks CEO Change, Divestitures, and Board Refresh After Years of Underperformance
Summary
Barington (shareholder since 2022) criticizes Matthews’ 18-year CEO Joseph Bartolacci for massive underperformance—just 8.9% TSR vs 629%
